By Rebecca Ashfiled (*) – A vaccine against COVID-19 is urgently ... our clinical trial of the vaccine ChAdOx1 nCoV-19 (also known as AZD1222), designed by the University of Oxford and developed ...

A new pandemic science hub is being created to develop treatments for lung infections such as Covid-19. The hub at the ...

Oxford University’s Sir John Bell says sharp fall in death rate due to existing vaccines allows for a change in priorities ...

Scientists have released the first real-world data from Africa on the effectiveness of two doses of AstraZeneca/ChaAd0x-1 ...

The researchers also found that although men and women are equally susceptible to the SARS-CoV-2 virus, men tend to have more ...

The University of ... Investigator of the trial, said: 'Here in Oxford, we have developed safe, controlled ways of studying malaria, typhoid and COVID-19 infections in volunteers.

So far, the studies have revolved around the effects and side-effects of vaccines against coronavirus ... Infection and Immunity, and Chief Investigator on the Oxford vaccine trial.

A fourth dose of an mRNA covid-19 ... the trial, 166 participants who had received a third dose of the Pfizer/BioNTech vaccine, following two initial Pfizer/BioNTech or University of Oxford ...

The University of ... Investigator of the trial, said: "Here in Oxford, we have developed safe, controlled ways of studying malaria, typhoid and COVID-19 infections in volunteers.

Scientists have released the first real-world data from Africa on the effectiveness of two doses of AstraZeneca/ChaAd0x-1 ...